CervoMed (CRVO) Announces Up to $149.4M Private Placement Financing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
March 28, 2024 8:30 AM EDTFunding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital
$50 million financing upfront with up to an additional $99.4 million tied to exercise of warrants
Pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders (the Company), today announced that it has entered into a definitive securities purchase agreement for a private... More
